Note 1 - Organization and Operations (Tables)

3 Months Ended

Mar. 31, 2019

Notes Tables

Proportions of Patients Experiencing Adverse Events [Table Text Block]

	Vonapanitase N=399			Placebo N=204
Vascular Stenosis		35.1	%		41.7	%
Fistula Thrombosis		16.8	%		18.6	%
Local swelling		5.0	%		2.0	%
Hematoma		5.0	%		3.9	%